ANVISA registration 81816720091ActiveIMUNOGLOBULINA G (IgG) PARA VÍRUS EPSTEIN-BARR (EBV)
ANVISA Registration Number: 81816720091ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDAVIRCELL S.L.Risk Class IV
Device names
- Technical name
- IMUNOGLOBULINA G (IgG) PARA VÍRUS EPSTEIN-BARR (EBV)
- Risk class
- Class IV
Registration details
- Registration Number
- 81816720091
- Process Number
- 25351114515202501
- CNPJ
- 31167508000102
Company information
- Registration Holder
- ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA
- Manufacturer
- VIRCELL S.L.
- Manufacturing Country
- Spain
PT: ESPANHA
Dates and status
- Publication Date
- Mar 09, 2026
- Status
- Active
About this record
Access comprehensive regulatory information for IMUNOGLOBULINA G (IgG) PARA VÍRUS EPSTEIN-BARR (EBV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 81816720091 and manufactured by VIRCELL S.L.. The registration is held by ALIFAX BRASIL COMER., EXP., IMP., DIST. DE EQUIPAMENTOS E REAGENTES PARA DIAGNOSTICO IN VITRO LTDA with validity until Mar 09, 2036.
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.